By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Radius Health 

950 Winter Street

Waltham  Massachusetts  02451  U.S.A.
Phone: 617-551-4000 Fax: 617-551-4701


Radius is a science-driven biopharmaceutical company focused on developing new therapeutics for patients with osteoporosis as well as other serious endocrine-mediated diseases.

Radius is committed to the research and development of new therapeutics for the large and underserved osteoporosis market.

Key Statistics

Ownership: Public

Web Site: Radius Health
Symbol: RDUS


Company News
10 Massachusetts Biotechs that Grew Their Headcount by at Least 40% in 2015 3/23/2016 6:40:48 AM
Five Companies Face Big FDA Decisions This Month 3/14/2016 6:39:10 AM
Radius Health (RDUS) To Present At The Cowen and Company 36th Annual Health Care Conference 3/1/2016 8:23:19 AM
Radius Health (RDUS) Appoints Former GlaxoSmithKline (GSK) CEO Jean-Pierre Garnier To Board Of Directors 12/8/2015 10:03:06 AM
Radius Health (RDUS) Announces Conference Call And Webcast On New Data For Investigational Drug RAD1901 To Be Presented At San Antonio Breast Cancer Symposium 2015 12/7/2015 11:47:11 AM
Radius Health (RDUS) Delays Osteoporosis Drug Application in the U.S. to Avoid Rush, Respect Staffers' Holidays 11/18/2015 6:03:54 AM
Radius Health (RDUS) Has Submitted A Marketing Authorization Application For The Investigational Drug Abaloparatide-SC For The Treatment Of Postmenopausal Osteoporosis In Europe 11/17/2015 11:35:59 AM
Radius Health (RDUS) To Host 2015 Investor Day On November 17th In New York City 11/13/2015 10:20:35 AM
Radius Health (RDUS) To Present At The Goldman, Sachs & Co. U.S. Emerging/SMID Cap Growth Conference 11/11/2015 10:25:58 AM
Radius Health (RDUS) Reports Third Quarter 2015 Financial And Operating Results 11/5/2015 11:26:37 AM